Authors


Michael Beshir, PharmD

Latest:

Pharmacists Are Key Players in Critical Care, Enhancing Patient Outcomes in the ICU

Despite evidence supporting the benefit of placing pharmacists in the ICU, there is still reluctance to widely adopt decentralized pharmacist models, largely due to immediate cost concerns and underrepresentation of pharmacy leaders in decision-making roles.


Donna Breese, PharmD

Latest:

Educational Opportunities Exist for the Pharmaceutical Care of Animals

Interested individuals may gain certification or continuing-education credits, many of which are available through the American College of Veterinary Pharmacists.



Mary Lynn McPherson, PharmD, MA, MDE, FAAHPM

Latest:

Pharmacists Participating in Advanced Pain Management Modalities for Refractory Pain

Patient selection is a key factor in the safe and effective administration of advanced pain management modalities.


Earl B Ettienne, BScPharm, MBA, LPD

Latest:

The European Medicines Agency: A Modern Robin Hood?

Many studies with a stated goal of advancing child health care in administratively-defined minors have no clinical value and may even harm young patients.


Monique Hook, PharmD

Latest:

The Psychological Impact of GLP-1 Receptor Agonists: An Ongoing Investigation

Case reports have shown a potential association with adverse psychological effects.


Sara Jo Santangelo

Latest:

340B Assists Patients and Institutions

How much does this federal program affect the success of the health care parties involved?


Omar Hajmousa, PharmD

Latest:

A Hospital’s Outpatient Pharmacies Attempt to Reduce DIR Fees Using Performance Reports

This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.


Sheetal Nariani

Latest:

How the Corporate World, Government Worked Together to Deliver a Solution to the COVID-19 Pandemic

The alliance between pharmaceutical partners and government organizations signals the possibilities of shared resources in meeting global crises.



Andrea Bush, PharmD, AAHIVP

Latest:

A Guide to Administering Influenza Vaccines in Special Populations: Focus on Patients Who Are Immunocompromised

Expanding pharmacist–patient care services to include vaccine promotion and administration within ambulatory clinics is an example of the expanding role of pharmacists and their contribution to primary care practice.



Elizabeth H. Bernauer

Latest:

Telehealth Proves of Great Value During COVID-19

But state-to-state communications and inconsistencies related to licensing present legal issues.


Mike Munsell, PhD

Latest:

Data-Driven Development: How Real-World Data and AI Are Transforming Clinical Trials

Real-world data and artificial intelligence (AI) are poised to revolutionize drug development by optimizing clinical trials and regulatory approvals, if data quality and patient privacy challenges are addressed.


Asmaa Abouseria, BPS, PharmD Candidate

Latest:

Zuranolone Offers An Innovative Treatment for Postpartum Depression

Zuranolone enhances health care providers’ ability to address the complex needs of patients with PPD, offering new hope for rapid and sustained relief from depressive symptoms.


Kennedy Schaal

Latest:

AI in Biomedical Research Is Revolutionizing Drug Development, Clinical Innovation

AI is expected to significantly quicken the pace of drug design and development, while improving the success rate of new medicines.


Tracey James, RPh

Latest:

Planning for the New Year in Specialty Pharmacy: Tips to Help Patients Get Hassle-Free Refills

In specialty pharmacy, many patients take steps to manage their prescription benefits before the new year.


Dat Ngo, PharmD

Latest:

The Impact of USP 797, USP 800 on Compounding Pharmacies

USP 800 was a necessary step to maximize safety, but it also recommended many institutions reevaluate their facilities, equipment, processes, and staffing capacity, potentially costing millions of dollars.


Stephen Rayborn, PharmD Candidate

Latest:

Equal but Not the Same—2021 Update on Influenza Vaccines

As COVID-19 vaccination efforts continue, it is more important than ever for pharmacists to be equipped with the knowledge and resources to bust the myths surrounding vaccinations, particularly in preparation for the upcoming influenza season, which is expected to occur from October 2021 to May 2022.


Harsha Rajasimha, MD

Latest:

Global Patient Registries Can Advance Opportunities for Rare Disease Research

Collaboration and knowledge sharing amongst rare disease researchers can be difficult, as these researchers are often spread out throughout the world.


Soutsada Sikhounchanh, BS, PharmD Candidate

Latest:

Transformative Leadership Can and Should be Practiced by Everyone in the Pharmacy Organization

A transformational leader can make the difference between an efficient, profitable organization and one that is mired in mediocrity.


Samantha Gorski, PharmD Candidate

Latest:

Patients With Cancer Have Unique Considerations for Influenza Vaccination

Proper timing and vaccine selection are crucial for optimal immune responses.


Ashley Yarabinec, PharmD, BCGP

Latest:

Empower Prospective Pharmacists through Children’s Books

This short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.


Jennifer A. Kuivinen, BSPharm, CIP

Latest:

Fecal Microbiota Transplantation Could Be the Answer to the Global Threat of Antimicrobial Resistance

Scientists hypothesize that fecal microbiota transplant restores the recipient’s gut microbiota to an environment that mimics the healthy donor’s microbiota


Dae Y. Lee, PharmD, Esq

Latest:

Navigating the Changing Tides of PBM Audits: A Forecast and Strategy for Independent Pharmacies

By understanding the nuances of PBM audit strategies, pharmacies can implement proactive measures to mitigate risks of recoupment, payment suspensions, and, in severe cases, network termination.


Charles E. Libby, RPh, MS

Latest:

Oncology Overview: Idelalisib in Blood Cancers

Approved indications for idelalisib include relapsed chronic lymphocytic leukemia, small lymphocytic lymphoma, and follicular B-cell non-Hodgkin lymphoma.


Jay Koirala

Latest:

Social Determinants of Health Matter When Treating Patients With Breast Cancer

Pharmacists play a critical role in treating patients with breast cancer and can help address their social determinant of health challenges.


William Schimmel

Latest:

Advocate for Greater Pharmacy Technician Roles

Multiple state and federal laws since the COVID-19 pandemic highlight the growing role of technicians


Jeff Trinkl, MD

Latest:

Study: Guillain-Barré Five Times More Likely in Unvaccinated COVID-19-Positive Patients Than Vaccinated Patients

Patients can sometimes develop Guillain-Barre syndrome after having a recent respiratory illness or digestive tract infection and, in rare cases, after receiving certain vaccines.


Katelyn M. Skeeters, PharmD Candidate

Latest:

Minnesota Fights Back Against Rising Insulin Costs

Alec Smith Insulin Affordability Act provides citizens with a long-term solution to diabetes expenditures.